Final report of a prospective randomized study on thoracic radiotherapy target volumes for limited-stage small cell lung cancer

医学 放射治疗 预防性头颅照射 肺癌 阶段(地层学) 化疗 随机对照试验 前瞻性队列研究 外科 淋巴结 内科学 古生物学 心肌梗塞 传统PCI 生物
作者
Xiao Hu,Yong Bao,Yujin Xu,Li Zhang,Jin Wang,Honglian Ma,Ying Jin,Xiaoling Xu,Zhengbo Song,Fang Peng,Huarong Tang,Min Fang,Yue Kong,Mengyuan Chen,Baiqiang Dong,Xinmin Yu,Hongyang Lu,Yiping Zhang,Yun Fan,Ming Chen
出处
期刊:Chinese Journal of Radiation Oncology [Chinese Medical Association]
卷期号:27 (12): 1046-1050
标识
DOI:10.3760/cma.j.issn.1004-4221.2018.12.003
摘要

Objective In view of the controversy over radiotherapy target volume for patients with limited-stage small cell lung cancer (SCLC), a prospective randomized controlled trial was conducted to compare the impact of different radiotherapy target volumes on prognosis. Methods After 2 cycles of EP chemotherapy, patients without progressive disease were randomly assigned to receive thoracic radiotherapy (TRT) to either the post-or pre-chemotherapy primary tumour extent as study arm or control. Involved field radiotherapy (IFRT) to the entire metastatic lymph node regions was applied for both arms. TRT consisted of 45 Gy/30Fx/19 d administered concurrently with cycle 3 chemotherapy. Prophylactic cranial irradiation was administered to patients achieved complete or partial remission. Kaplan-Meier method was used for survival analysis. Results Between June 2002 and December 2017, 159 and 150 patients were randomly assigned to study arm and control respectively. The 1-, 2-, and 5-year local/regional control rates were 79.4%, 61.5% and 60.1% respectively in the study arm versus 79.8%, 66.5%, and 57.3% in the control arm (P=0.73). The median OS time was 22.1 months in the study arm (95%CI, 18.2-26.0 months) and 26.9 months (95%CI, 23.5-30.3 months) in the control arm, the 1-, 3-, 5-, and 7-year OS rates were 81.1%, 31.6%, 23.9% and 22.2% respectively in the study arm versus 85.3%, 36.6%, 26.1% and 20.0% in the control arm (P=0.51). Grade 2-3 acute esophagitis was developed in 32.9% and 43.2% of patients respectively in study arm and control arm (P=0.01), while grade 2-3 pulmonary fibrosis was observed in 2.0% and 10.9% of patients (P=0.01) respectively. Conclusions For patients with limited-stage SCLC who received induction chemotherapy, thoracic radiotherapy can be limited to post-chemotherapy tumour extent and IFRT can be routinely applied. Key words: Lung neoplasms/radiotherapy; Radiotherapy target volume; Prospective study
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
啊娴子发布了新的文献求助10
刚刚
CipherSage应助lkf采纳,获得10
1秒前
咖啡豆发布了新的文献求助10
1秒前
1秒前
shime完成签到,获得积分10
1秒前
1秒前
ccc发布了新的文献求助10
2秒前
bo发布了新的文献求助10
3秒前
move发布了新的文献求助30
3秒前
3秒前
3秒前
3秒前
3秒前
徐嘉女完成签到,获得积分10
3秒前
痞子wu完成签到,获得积分10
4秒前
5秒前
5秒前
KK发布了新的文献求助10
7秒前
pliliyi发布了新的文献求助10
7秒前
7秒前
8秒前
whatever举报马茹求助涉嫌违规
8秒前
8秒前
lxy发布了新的文献求助10
8秒前
8秒前
9秒前
顾矜应助一期一会采纳,获得10
9秒前
甜甜语堂完成签到,获得积分10
10秒前
long完成签到,获得积分10
10秒前
ww发布了新的文献求助10
11秒前
12秒前
风趣笙关注了科研通微信公众号
12秒前
12秒前
move完成签到,获得积分10
12秒前
银河系小熊完成签到,获得积分10
13秒前
小蘑菇应助Rtian采纳,获得10
13秒前
WN发布了新的文献求助10
13秒前
科研通AI6.3应助seven采纳,获得10
13秒前
英姑应助没所谓采纳,获得10
13秒前
菠菜应助阿王采纳,获得10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Cronologia da história de Macau 5000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
Electrode Potentials 550
Trees of tropical Asia : an illustrated guide to diversity 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6978077
求助须知:如何正确求助?哪些是违规求助? 8657171
关于积分的说明 18354485
捐赠科研通 6439650
什么是DOI,文献DOI怎么找? 3092025
关于科研通互助平台的介绍 2148138
邀请新用户注册赠送积分活动 2068541